Masimo ROA 2007-2018 | MASI

Current and historical return on assets (ROA) values for Masimo (MASI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Masimo ROA for the three months ending September 30, 2018 was 16.44%.
Masimo ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.15B $1.10B 14.75%
2018-06-30 $0.13B $1.01B 13.27%
2018-03-31 $0.13B $0.95B 13.78%
2017-12-31 $0.13B $0.91B 14.73%
2017-09-30 $0.35B $0.91B 39.76%
2017-06-30 $0.34B $0.90B 42.05%
2017-03-31 $0.33B $0.88B 44.20%
2016-12-31 $0.30B $0.82B 44.86%
2016-09-30 $0.11B $0.64B 17.85%
2016-06-30 $0.10B $0.60B 16.81%
2016-03-31 $0.09B $0.62B 15.09%
2015-12-31 $0.08B $0.60B 14.19%
2015-09-30 $0.08B $0.58B 13.90%
2015-06-30 $0.08B $0.58B 13.48%
2015-03-31 $0.07B $0.58B 13.08%
2014-12-31 $0.07B $0.57B 14.21%
2014-09-30 $0.06B $0.53B 12.65%
2014-06-30 $0.06B $0.50B 13.59%
2014-03-31 $0.07B $0.46B 15.09%
2013-12-31 $0.06B $0.44B 14.04%
2013-09-30 $0.06B $0.43B 16.12%
2013-06-30 $0.06B $0.40B 15.80%
2013-03-31 $0.06B $0.39B 16.22%
2012-12-31 $0.06B $0.38B 16.30%
2012-09-30 $0.06B $0.41B 16.14%
2012-06-30 $0.06B $0.38B 16.79%
2012-03-31 $0.06B $0.38B 16.85%
2011-12-31 $0.06B $0.37B 18.03%
2011-09-30 $0.07B $0.37B 19.35%
2011-06-30 $0.07B $0.35B 20.35%
2011-03-31 $0.06B $0.33B 20.22%
2010-12-31 $0.07B $0.31B 23.76%
2010-09-30 $0.07B $0.33B 22.27%
2010-06-30 $0.07B $0.30B 21.18%
2010-03-31 $0.07B $0.29B 20.63%
2009-12-31 $0.05B $0.36B 16.15%
2009-09-30 $0.04B $0.34B 12.16%
2009-06-30 $0.04B $0.32B 12.83%
2009-03-31 $0.04B $0.31B 12.86%
2008-12-31 $0.03B $0.29B 12.28%
2008-09-30 $0.04B $0.27B 17.87%
2008-06-30 $0.04B $0.25B 16.19%
2008-03-31 $0.03B $0.23B 13.92%
2007-12-31 $0.02B $0.24B 14.49%
2007-09-30 $0.02B $0.23B 15.04%
2007-06-30 $0.01B $0.17B 27.59%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.392B $0.798B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $96.884B 22.58
Intuitive Surgical (ISRG) United States $61.959B 60.96
Edwards Lifesciences (EW) United States $35.206B 37.68
Fresenius Medical Care AG KGaA (FMS) Germany $21.571B 14.59
IDEXX Laboratories (IDXX) United States $17.322B 49.48
ABIOMED (ABMD) United States $15.032B 108.01
DexCom (DXCM) United States $13.284B 0.00
Hologic (HOLX) United States $12.760B 19.70
Teleflex (TFX) United States $11.860B 26.92
Varian Medical Systems (VAR) United States $11.648B 28.99
STERIS (STE) United Kingdom $9.532B 25.29
Penumbra (PEN) United States $4.899B 295.83
LivaNova (LIVN) United Kingdom $4.495B 28.85
Globus Medical (GMED) United States $4.283B 26.85
Integra LifeSciences Holdings (IART) United States $4.007B 19.52
Wright Medical Group (WMGI) Netherlands $3.610B 0.00
Cantel Medical (CMD) United States $3.301B 32.56
Inogen (INGN) United States $3.205B 69.18
Integer Holdings (ITGR) United States $2.612B 21.86
Tandem Diabetes Care (TNDM) United States $2.498B 0.00
Glaukos (GKOS) United States $2.188B 0.00
Halyard Health (AVNS) United States $2.145B 19.33
OPKO Health (OPK) United States $2.127B 0.00
Nevro (NVRO) United States $1.282B 0.00
Luminex (LMNX) United States $1.187B 42.94
Tactile Systems Technology (TCMD) United States $1.168B 185.91
Natus Medical (BABY) United States $1.151B 24.18
Pacific Biosciences Of California (PACB) United States $1.098B 0.00
CryoLife (CRY) United States $1.051B 91.74
Orthofix (OFIX) United States $0.983B 28.38
Accelerate Diagnostics (AXDX) United States $0.908B 0.00
Intersect ENT (XENT) United States $0.895B 0.00
Mesa Laboratories (MLAB) United States $0.832B 49.21
AngioDynamics (ANGO) United States $0.775B 25.16
ViewRay (VRAY) United States $0.747B 0.00
Veracyte (VCYT) United States $0.701B 0.00
AxoGen (AXGN) United States $0.614B 0.00
TransEnterix (TRXC) United States $0.603B 0.00
Si-Bone (SIBN) United States $0.505B 0.00
OrthoPediatrics (KIDS) United States $0.436B 0.00
Quotient (QTNT) Switzerland $0.403B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.392B 0.00
Sientra (SIEN) United States $0.372B 0.00
Fluidigm (FLDM) United States $0.343B 0.00
GenMark Diagnostics (GNMK) United States $0.336B 0.00
Accuray (ARAY) United States $0.335B 0.00
SeaSpine Holdings (SPNE) United States $0.289B 0.00
IRadimed (IRMD) United States $0.282B 73.71
RTI Surgical (RTIX) United States $0.272B 42.90
Neuronetics (STIM) United States $0.253B 0.00
Pulse Biosciences (PLSE) United States $0.252B 0.00
Nuvectra (NVTR) United States $0.247B 0.00
CRH Medical (CRHM) Canada $0.237B 40.88
Corindus Vascular Robotics (CVRS) United States $0.220B 0.00
Helius Medical Technologies (HSDT) United States $0.212B 0.00
T2 Biosystems (TTOO) United States $0.159B 0.00
Sensus Healthcare (SRTS) United States $0.131B 0.00
Ra Medical Systems (RMED) United States $0.110B 0.00
Ekso Bionics Holdings (EKSO) United States $0.105B 0.00
EDAP TMS (EDAP) France $0.077B 0.00
Biosig Technologies (BSGM) United States $0.074B 0.00
Alphatec Holdings (ATEC) United States $0.074B 0.00
Apollo Endosurgery (APEN) United States $0.074B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.066B 0.00
Second Sight Medical Products (EYES) United States $0.061B 0.00
Vermillion (VRML) United States $0.060B 0.00
Titan Medical (TMDI) Canada $0.046B 0.00
Electromed (ELMD) United States $0.042B 20.00
Restoration Robotics (HAIR) United States $0.041B 0.00
OBALON THERPTCS (OBLN) United States $0.040B 0.00
Viveve Medical (VIVE) United States $0.038B 0.00
ConforMIS (CFMS) United States $0.037B 0.00
Xtant Medical Holdings (XTNT) United States $0.030B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
Microbot Medical (MBOT) United States $0.026B 0.00
PAVmed (PAVM) United States $0.026B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.023B 0.00
DarioHealth (DRIO) Israel $0.022B 0.00
Dynatronics (DYNT) United States $0.022B 0.00
Neovasc (NVCN) Canada $0.020B 0.00
American Shared Hospital Services (AMS) United States $0.015B 11.22
Bioanalytical Systems (BASI) United States $0.015B 71.00
Nanovibronix (NAOV) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Presbia (LENS) Ireland $0.009B 0.00
ReWalk Robotics (RWLK) Israel $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.007B 0.00
Avinger (AVGR) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Amedica (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00